The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
When is a pathologic diagnosis preferred before stereotactic ablative radiotherapy for stage I lung cancer? A decision analysis.
Alexander V. Louie
No relevant relationships to disclose
Suresh Senan
Consultant or Advisory Role - Varian Medical Systems
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems
Pretesh Patel
No relevant relationships to disclose
Bart S Ferket
No relevant relationships to disclose
Frank J Lagerwaard
Honoraria - BrainLAB; Varian Medical Systems
Research Funding - Varian Medical Systems
George Rodrigues
No relevant relationships to disclose
Joseph Kamel Salama
No relevant relationships to disclose
Christopher Ryan Kelsey
No relevant relationships to disclose
David Palma
No relevant relationships to disclose
Myriam Hunink
No relevant relationships to disclose